The pathophysiology and management of vascular calcification in chronic kidney disease patients
INTRODUCTION: Vascular calcification (VC) which is the pathological mineral deposition in the vascular system, predominantly at the intimal and medial layer of the vessel wall, is an important comorbidity in patients with chronic kidney disease (CKD) leading to significant morbidity and mortality while necessitating appropriate treatment. Our review aims to provide an in-depth analysis of the current understanding of VC.
AREAS COVERED: In this review, we first discuss the pathophysiology of VC in CKD patients, then we explain the methods to predict and assess VC. Afterwards, we provide the currently available as well as the potential therapeutic approaches of VC. We finally discuss our understanding regarding the current situation surrounding VC in our expert opinion section.
EXPERT OPINION: Predicting, assessing and treating VC is crucial and the future advances in the field of research surrounding VC will potentially occur in one or more of these three areas of clinical management. There is a current lack of evidence and consensus regarding specific therapeutic options for alleviating VC and this situation may not necessitate VC to be determined, detected, and documented before the available options are implemented. Regardless, the prediction and assessment of VC is still important and requires further improvement together with the developments in therapeutic alternatives. The future has the potential to bring better research which would guide and improve the management of this patient group. A more specialized approach consisting of targeted therapies and more tailored management plans for patients with CKD and VC is on the horizon.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Expert review of cardiovascular therapy - 21(2023), 2 vom: 30. Feb., Seite 75-85 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kanbay, Mehmet [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chronic kidney disease |
|---|
| Anmerkungen: |
Date Completed 22.02.2023 Date Revised 22.02.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/14779072.2023.2174525 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352264829 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352264829 | ||
| 003 | DE-627 | ||
| 005 | 20231226053323.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14779072.2023.2174525 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1174.xml |
| 035 | |a (DE-627)NLM352264829 | ||
| 035 | |a (NLM)36716079 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kanbay, Mehmet |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The pathophysiology and management of vascular calcification in chronic kidney disease patients |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.02.2023 | ||
| 500 | |a Date Revised 22.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION: Vascular calcification (VC) which is the pathological mineral deposition in the vascular system, predominantly at the intimal and medial layer of the vessel wall, is an important comorbidity in patients with chronic kidney disease (CKD) leading to significant morbidity and mortality while necessitating appropriate treatment. Our review aims to provide an in-depth analysis of the current understanding of VC | ||
| 520 | |a AREAS COVERED: In this review, we first discuss the pathophysiology of VC in CKD patients, then we explain the methods to predict and assess VC. Afterwards, we provide the currently available as well as the potential therapeutic approaches of VC. We finally discuss our understanding regarding the current situation surrounding VC in our expert opinion section | ||
| 520 | |a EXPERT OPINION: Predicting, assessing and treating VC is crucial and the future advances in the field of research surrounding VC will potentially occur in one or more of these three areas of clinical management. There is a current lack of evidence and consensus regarding specific therapeutic options for alleviating VC and this situation may not necessitate VC to be determined, detected, and documented before the available options are implemented. Regardless, the prediction and assessment of VC is still important and requires further improvement together with the developments in therapeutic alternatives. The future has the potential to bring better research which would guide and improve the management of this patient group. A more specialized approach consisting of targeted therapies and more tailored management plans for patients with CKD and VC is on the horizon | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Vascular calcification | |
| 650 | 4 | |a chronic kidney disease | |
| 650 | 4 | |a intimal calcification | |
| 650 | 4 | |a therapeutics | |
| 700 | 1 | |a Copur, Sidar |e verfasserin |4 aut | |
| 700 | 1 | |a Tanriover, Cem |e verfasserin |4 aut | |
| 700 | 1 | |a Yavuz, Furkan |e verfasserin |4 aut | |
| 700 | 1 | |a Galassi, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Ciceri, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Cozzolino, Mario |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert review of cardiovascular therapy |d 2003 |g 21(2023), 2 vom: 30. Feb., Seite 75-85 |w (DE-627)NLM147291070 |x 1744-8344 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2023 |g number:2 |g day:30 |g month:02 |g pages:75-85 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14779072.2023.2174525 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2023 |e 2 |b 30 |c 02 |h 75-85 | ||